ChemPartner PharmaTech Co., Ltd. — Investor Relations & Filings
ChemPartner PharmaTech Co., Ltd. is a global research and development organization providing comprehensive drug discovery and development services. Operating as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), the company supports pharmaceutical and biotechnology clients through an integrated service platform. Core capabilities include medicinal chemistry, biology, pharmacology, drug metabolism and pharmacokinetics (DMPK), and toxicology. The organization also offers specialized expertise in biologics discovery, protein engineering, and antibody development. ChemPartner facilitates the transition from early-stage research to clinical development through its pharmaceutical development and manufacturing capabilities, utilizing advanced technology to accelerate the discovery and production of novel therapeutic agents.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于全资子公司与专业投资机构共同投资的公告 | 2025-09-03 | Chinese | |
| 第六届董事会第十一次会议决议公告 | 2025-09-03 | Chinese | |
| 关于设立全资子公司进展暨完成工商登记的公告 | 2025-09-03 | Chinese | |
| 2025年半年度报告摘要 | 2025-08-28 | Chinese | |
| 2025年半年度报告 | 2025-08-28 | Chinese | |
| 2025年半年度非经营性资金占用及其他关联资金往来情况汇总表 | 2025-08-28 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 36045884 | 关于全资子公司与专业投资机构共同投资的公告 | 2025-09-03 | Chinese | ||
| 36045875 | 第六届董事会第十一次会议决议公告 | 2025-09-03 | Chinese | ||
| 36045858 | 关于设立全资子公司进展暨完成工商登记的公告 | 2025-09-03 | Chinese | ||
| 36045850 | 2025年半年度报告摘要 | 2025-08-28 | Chinese | ||
| 36045840 | 2025年半年度报告 | 2025-08-28 | Chinese | ||
| 36045813 | 2025年半年度非经营性资金占用及其他关联资金往来情况汇总表 | 2025-08-28 | Chinese | ||
| 36045803 | 董事会决议公告 | 2025-08-28 | Chinese | ||
| 36045794 | 最近一年的财务报告及其审计报告以及最近一期的财务报告 | 2025-08-27 | Chinese | ||
| 36045579 | 中信证券股份有限公司关于睿智医药科技股份有限公司2024年度向特定对象发行股票之上市保荐书 | 2025-08-27 | Chinese | ||
| 36045574 | 中信证券股份有限公司关于睿智医药科技股份有限公司2024年度向特定对象发行股票之发行保荐书 | 2025-08-27 | Chinese | ||
| 36045532 | 关于2024年度向特定对象发行股票申请获得深圳证券交易所受理的公告 | 2025-08-27 | Chinese | ||
| 36045524 | 北京市竞天公诚律师事务所关于睿智医药科技股份有限公司2024年度向特定对象发行股票的法律意见书 | 2025-08-27 | Chinese | ||
| 36045512 | 2024年度向特定对象发行股票募集说明书（申报稿） | 2025-08-27 | Chinese | ||
| 36045476 | 关于设立全资子公司进展暨完成工商登记的公告 | 2025-08-12 | Chinese | ||
| 36045463 | 2025年限制性股票激励计划首次授予激励对象名单（授予日） | 2025-07-11 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
ChemPartner PharmaTech Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55161/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55161 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55161 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55161 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55161}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ChemPartner PharmaTech Co., Ltd. (id: 55161)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.